NAD+ & SIRT3 Power: New NMN-EVs Reverse Skin Aging in Mice

Picture your cells as tiny factories. Over time, they accumulate damage: DNA scars, rundown energy plants (mitochondria), and rubbish piling up. These are the hallmarks of aging.

One unsung hero tackling this mess? NAD⁺ (nicotinamide adenine dinucleotide)—a vital molecule that powers DNA repair, tweaks metabolism, and fuels the sirtuin family of enzymes (SIRT1–7). Unfortunately, NAD⁺ levels plummet as we age, hampering those repair crews and energy systems.

That’s where NMN (β-nicotinamide mononucleotide) steps in. NMN is an immediate precursor to NAD⁺. Animal studies show that NMN boosts NAD⁺, revs up mitochondria, supports DNA repair, and even improves insulin sensitivity and endurance in humans .

But NMN has warts: it’s water-soluble, unstable, and gets shredded before reaching the cells that need it most.

Enter mesenchymal stromal cell extracellular vesicles (MSC‑sEVs)

MSCs, grown from bone marrow, fat, or umbilical cord, don’t just become tissue—they secrete small extracellular vesicles (sEVs), nanoscale lipid packages loaded with proteins, RNAs, and signaling mojo.

These sEVs are like your friend who shows up with exactly what you need: anti-inflammatory signals, antioxidants, and rejuvenating microRNAs. They’re showing promise across anti-aging therapies, from brain to skin.

The groundbreaking combo: NMN‑loaded MSC-sEVs

A study from June 2025 (Sun et al.) created a clever hybrid: MSC-sEVs packed with NMN (called NMN‑sEVs) using electroporation—like a tiny molecular coaxing to load the vesicles.

Results? Stunning:

• In D-galactose–aged mice, topical nano-microneedle delivery of NMN‑sEVs visibly rejuvenated skin—thicker dermis, more collagen, less oxidative stress.
• On a cellular level, they dialed down senescence markers (p21, p53, ROS, β‑gal) and restored mitochondrial membrane potential.
• Crucially, NAD⁺ surged inside cells and SIRT3 protein levels rose, reactivating mitophagy—the cell’s clean-up crew for dysfunctional mitochondria. Block SIRT3 with 3‑TYP, and all benefits vanish—making it clear: it’s a NAD⁺ → SIRT3 → mitophagy axis.

Encapsulation stats? Around 44% efficiency, packing ~4,400 µg NMN per 10¹⁰ sEVs.

Zooming out: Why SIRT3 + mitophagy matter

SIRT3 is a mitochondrial deacetylase—think of it as a tidy-up enforcer. It activates enzymes that turn ATP production up and oxidative stress down. Higher SIRT3 ties to longer lifespan, better heart and brain health .

Beyond skin, boosting NAD⁺ and SIRT3 improves mitochondrial quality control (through mitophagy) in liver, kidney, heart—and helps protect muscle and insulin response.Plus, blocking NAD⁺ destruction by CD38 enzyme in macrophages restores NAD⁺ and boosts mitochondrial health.

Making it human: where’s the proof?

We don’t want just animal data. Good news: NMN in humans shows benefits:

• Prediabetic women gained muscle insulin sensitivity (2021 study).
• Amateur athletes improved aerobic capacity and subjective health (2023 trial).
• Multiple trials show safety up to 500 mg in healthy men.

And MSC‑EVs from human adipose or umbilical cord have already reduced wrinkles, boosted skin hydration, cut ROS and DNA damage in human models and UV‑aged skin.

Combine that with NMN’s NAD-boost? The NMN‑sEVs hybrid could be skin’s rich new superhero.

The narrative arc: from sci‑fi to skincare

Imagine your skin as Gotham under siege—UV strikes, molecular grime stacking, energy plants failing. The NMN‑sEVs arrive in stealth, armored nano-microneedles, riding sEVs that deliver NMN right where it’s needed.

Once inside cells, NAD⁺ revs up. SIRT3 sounds the alarm, signaling damaged mitochondria for mitophagy. Autophagy crews sweep in, clear debris, restore power, and escalate collagen production. Skin doesn’t just get younger—it gets a reboot.

It’s like assembling a crack team: the techy NMN specialist, the tactical MSC‑sEV support, and SIRT3, the field commander. And those tiny needles? The high-tech extraction dash from Mission Impossible.

But hold up—what’s next?

Human trials

So far, NMN‑sEVs have only been tested in mice. The next big step: safety and efficacy trials in humans. We want topical creams, microneedle patches, dose control, long-term effects.

Understanding trafficking

We know NMN‑sEVs load in and activate SIRT3, but which cargo does what? Proteomics and microRNA mapping need to reveal “who’s the real MVP” in that vesicle cocktail.

Expanding to other tissues

If it works for skin, could NMN‑sEVs be rebooters for muscle, brain, liver? Given systemic NAD decline and SIRT3’s role in heart, kidney, and brain, the ceiling is high .

Against inflammation

Remember CD38? Senescent cells lure macrophages that eat NAD⁺, worsening inflammation. Maybe sEVs can deliver CD38 inhibitors—or miRNAs—to shift immune behavior.

Key take-aways

• Aging is driven by NAD⁺ decline, mitochondrial damage, and cellular clutter.
• NMN restores NAD⁺; MSC-sEVs deliver precision payloads.
• NMN‑sEVs in the new study hit NAD⁺, boost SIRT3, revive mitophagy—and visibly delay skin aging in mice.
• Human MSC‑EVs already show skin rejuvenation. NMN shows systemic benefits.
• The blend could spark a paradigm shift—from topical wrinkle cream to repair-grade rejuvenation tech.

Final thoughts

Remember that feeling in the finale of an epic movie when the ragtag team prevails and restoration begins? That’s the vibe here. NMN‑sEVs aren’t just a serum—they’re the beginning of a cellular resistance movement, a whisper that aging isn’t simply accepted. This combo therapy might be the first round in a long campaign to restore function and grace—cell by cell, mitochondrion by mitochondrion.

And while we wait for clinical trials and FDA green lights, we’re at the cusp of something that feels more sci-fi than skincare—maybe like the next scene in a blockbuster where rejuvenation isn’t a dream, but a strategic mission.

References

1. Sun, Y. et al. (2025). Small extracellular vesicles derived from mesenchymal stromal cells loaded with β-nicotinamide mononucleotide activate NAD⁺/SIRT3 signaling pathway-mediated mitochondrial autophagy to delay skin aging. Stem Cell Research & Therapy.
2. Irie, J. et al. (2020). Effect of oral administration of nicotinamide mononucleotide on clinical parameters and NAD⁺ metabolism in healthy Japanese men. Endocrine Journal, 67(2), 153–160.
3. Yoshino, M. et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 372(6547), 1224–1229.
4. Martens, C.R. et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD⁺ in healthy middle-aged and older adults. Nature Communications, 9(1), 1286.
5. Mills, K.F. et al. (2016). Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metabolism, 24(6), 795–806.
6. Zhang, H. et al. (2016). CD38 is a key enzyme degrading NAD⁺ and promoting the aging process. Cell Metabolism, 23(4), 665–680.
7. Guo, Z. et al. (2023). Small extracellular vesicles from mesenchymal stem cells alleviate aging skin by enhancing collagen production and reducing oxidative damage. Cell Death & Disease, 14, 555.
8. Zhang, Y. et al. (2024). Extracellular vesicle-based strategies for skin rejuvenation: advances and prospects. Signal Transduction and Targeted Therapy, 9(1), 11.
9. Yue, F. et al. (2023). The role of mitophagy in human aging and age-related disease. Cells, 12(2), 345.
10. You, J.S. & Jones, P.A. (2012). Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell, 22(1), 9–20.
11. Canto, C. et al. (2015). NAD⁺ metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metabolism, 22(1), 31–53.
12. Gomes, A.P. et al. (2013). Declining NAD⁺ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell, 155(7), 1624–1638.
13. Zhou, B. et al. (2016). SIRT3 is critical for mitochondrial function and insulin resistance in skeletal muscle. Journal of Biological Chemistry, 291(3), 1264–1278.
14. Minhas, P.S. et al. (2019). Macrophage de novo NAD⁺ synthesis specifies immune function in aging and inflammation. Nature Immunology, 20(1), 50–63.
15. Grootaert, M.O.J. et al. (2021). Defective autophagy in vascular smooth muscle cells accelerates senescence and promotes neointima formation. Aging Cell, 20(3), e13331.
16. Zhou, T. et al. (2022). sEVs derived from umbilical cord MSCs promote collagen synthesis and skin repair in photoaging. Stem Cells International, 2022, 1–12.